PSI Journal Club: Limitations and Challenges with Mixed Model Repeated Measures (MMRM) Analysis
Moses Mwangi and Florian Lasch present their recent work on MMRM, with discussion lead by Geert Molenberghs.
Date: Wednesday 7th September 2022
Time: 16:00-17:00 BST
Speakers: Yongming Qu (Eli Lilly) and Solomon Harrar (University of Kentucky)
Our next journal club features two papers on the topic of “Estimating Treatment Effects”. Please join us to hear Yongming Qu (Eli Lilly) and Solomon Harrar (University of Kentucky) present their recent work. The webinar will be chaired by Ilya Lipkovich (Eli Lilly)
To view the flyer for this event, please click here.
This event is sponsored by Wiley.
This event is open to both Members and Non-Members of PSI.
REGISTER HERE: https://us06web.zoom.us/webinar/register/WN_YLURM98nQF6aSfAKxR91VA
Yongming Qu (Eli Lilly): Estimating the treatment effect for adherers using multiple imputation
Ye, Z, Harrar, SW. Estimation of multivariate treatment effects in contaminated clinical trials.
Pharmaceutical Statistics. 2022; 21( 3): 535- 565. doi:10.1002/pst.2185
Solomon Harrar (University of Kentucky): Estimation of multivariate treatment effects in contaminated clinical trials
Luo, J, Ruberg, SJ, Qu, Y. Estimating the treatment effect for adherers using multiple imputation.
Pharmaceutical Statistics. 2022; 21( 3): 525- 534. doi:10.1002/pst.2184
For each of these published papers there will be a 20 minute presentation by the author, followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
Moses Mwangi and Florian Lasch present their recent work on MMRM, with discussion lead by Geert Molenberghs.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Talks from speakers will cover an introduction to HTA and indirect comparisons for value assessment before focusing in more specifically on topics related to the use of indirect treatment comparisons for patient access.
Talks from the speakers will cover the use of R in a programming community, submitted to regulators using R, and also programming beyond R in C++ and Julia.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.